Michel Bublot
29Patents
6h-index
24Co-inventors
69Inventor score
Filing activity: Jan 5, 1995 → Nov 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6497883B1 | Porcine circovirus recombinant poxvirus vaccine | Chemistry; Metallurgy | 87 | Expired |
| US6943152B1 | DNA vaccine-PCV | Chemistry; Metallurgy | 75 | Expired |
| US5980906A | Live recombinant avian vaccine using an avian herpesvirus as vector | Chemistry; Metallurgy | 25 | Expired |
| US6033670A | Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus | Chemistry; Metallurgy | 16 | Expired |
| US5733554A | Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease | Chemistry; Metallurgy | 14 | Expired |
| US6153199A | Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus | Emerging Cross-Sectional Technologies | 7 | Expired |
| US9114108B2 | Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US6045803A | Live recombinant avian vaccine using an avian herpesvirus as vector | Chemistry; Metallurgy | 5 | Expired |
| US10323257B2 | Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US7910112B2 | Feline vaccines against avian influenza | Chemistry; Metallurgy | 4 | Active |
| US9555096B2 | Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US8871220B2 | Newcastle disease virus vectored avian vaccines | Chemistry; Metallurgy | 3 | Active |
| US9770502B2 | Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 3 | Active |
| US6306400A | Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis | Emerging Cross-Sectional Technologies | 3 | Expired |
| US8486418B2 | Recombinant avian paramyxovirus vaccine and method for making and using thereof | Chemistry; Metallurgy | 2 | Active |
| US9446118B2 | Newcastle disease virus vectored herpesvirus vaccines | Chemistry; Metallurgy | 2 | Active |
| US10822620B2 | Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US7250161B2 | Equine GM-CSF | Chemistry; Metallurgy | 2 | Expired |
| US8986706B2 | Newcastle disease virus vectored herpesvirus vaccines | Chemistry; Metallurgy | 2 | Active |
| US9616118B2 | Newcastle disease virus vectored avian vaccines | Chemistry; Metallurgy | 2 | Active |
| US8394384B2 | Recombinant avian influenza vaccine and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9101598B2 | Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10350286B2 | Newcastle disease virus vectored avian vaccines | Chemistry; Metallurgy | 1 | Active |
| US6645740B1 | Nucleic acids encodings equine GM-CSF | Chemistry; Metallurgy | 0 | Expired |
| US7871807B2 | Method for producing the flu virus | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.